Abstract: Findings with experimental rodent models reveal that exposures to dietary factors during the in utero and pubertal periods when the mammary gland is undergoing extensive modeling and re-modeling, alter susceptibility to develop mammary tumors. Similar observations have been made in humans: childhood exposure to genistein in soy or to some other bioactive food components reduces later breast cancer risk, although they may have no effect if consumed during adulthood. Thus, food components may be more effective in affecting cancer risk in some periods of life than others. Many of these dietary exposures modify fetal and postnatal hormonal environment, including changing the concentrations of estrogens and leptin. The hormonal alterations then may induce persistent epigenetic changes by affecting gene promoter regions or by inducing histone modifications that affect chromatin transcription. The targets of epigenetic changes are likely to be the terminal end buds (TEBs), the structures where carcinogen-induced mammary tumors in rats and mice are initiated. More specifically, the site of these changes in TEBs may be the stem cells and their niche; this might explain how an exposure early in life affects the risk of breast cancer decades later. Similar structures in women, called terminal ductal lobular units, are the sites where most human breast cancers rise. According to this hypothetical model, cancer is initiated only when the epigenetically altered cells are exposed to carcinogens/radiation, etc. during adult life. In a "normal" stem cell or its niche, cancer initiating exposures do not necessarily cause cancer, because the cells can either repair the damage or undergo apoptosis. Thus, the most likely molecular targets of early life dietary exposures are genes that regulate DNA adduct formation, repair DNA damage or induce apoptosis, such as genes affecting cellular metabolism, tumor suppressor genes or genes promoting cell survival. It is possible that some of these epigenetic changes also explain why the number of TEBs generally, but not always, correlates with breast cancer risk. This hypothesis may imply that adult intake of some bioactive dietary components reduces cancer risk increased by early life dietary exposures or inhibits tumor growth by reversing epigenetic changes in various molecular targets.
TERMINAL END BUDS AND BREAST CANCER RISK
Terminal end buds (TEBs) are the structures in a rodent mammary gland that give rise to malignant mammary tumors upon an exposure to a chemical carcinogen [1, 2] . Similar structures in a human breast, called terminal ductal lobular unit 1 (TDLU1), appear to be the sites of breast cancer initiation in most women [3] . The reason why tumors arise from TEB/TDLU1 is not entirely clear, but might relate to high cell proliferation in this structure [4] that is associated with increased levels of DNA adduct formation and reduced capacity to repair DNA damage [5] .
Since many breast cancers are initiated in the TEB/TDLU1, it has been proposed that the more TEBs there are in the developing mammary gland at the time the gland is exposed to an initiating event -for example to a carcinogen or radiation -the higher the cancer risk [6] . The evidence to support this idea originates from observations obtained in animal models indicating that exposures early in life to hormones, endocrine disruptors or dietary compounds that alter hormonal environment are associated with altered susceptibility to mammary tumorigenesis and changes in the number of TEBs [7] [8] [9] [10] [11] [12] [13] [14] [15] . Thus, the link between increased number of TEBs and higher cancer risk, and low number of TEBs and reduced breast cancer risk has been considered to be strong. However, this concept is challenged by findings indicating that some early life dietary modifications that reduce the number of TEBs in fact increase the susceptibility to mammary tumorigenesis [12] . Further, some dietary manipulations which reduce TEB numbers do not affect the risk of developing mammary tumors [16] . These observations suggest that the number of TEBs in the developing mammary gland is not always predictive of later cancer risk. The reason for these inconsistencies remains to be resolved.
The goal of this review is to discuss the role of TEBs in rodents in affecting breast cancer risk. Based on a literature review and data generated in our laboratory, the following hypothesis is proposed: Dietary exposures during early development epigenetically reprogram the expression of genes within the mammary gland, resulting the TEBs to exhibit altered susceptibility to malignant transformation. The genes whose expression is altered may be those that normally protect the cells from malignant transformation; i.e., prevent DNA adduct formation (antioxidant genes or genes that regulate cell metabolism), repair DNA (tumor suppressor genes), induce apoptosis, or inhibit cell proliferation. The cells within TEBs where the reprogramming takes place might be the mammary stem cells that have a long lifespan; this could explain how exposures that took place during early development can affect breast cancer risk in adulthood. Another possibility is that epigenetic changes occur in the stem cell niche, a location where stem cells reside for an indefinite period of time and where stem cells undergo division to produce progenitor cells. In animals exposed to early life dietary manipulations, the stem cell niche, upon an exposure to initiating agents, fails to protect the mammary stem cells in the TEBs from malignant transformation or makes the stem and uncommitted progenitor cells more susceptible for malignant transformation by inducing proliferation but inhibiting lineage specific differentiation.
DIETARY EXPOSURES DURING PERIODS OF MAM-MARY GLAND REMODELING AFFECT SUBSEQUENT BREAST CANCER RISK
Besides the link between reproductive factors and breast cancer, the search for factors involved in affecting susceptibility to initiation of this disease has left us relatively empty-handed. Diet is estimated to contribute to the etiology of 30-50% of all breast cancers; however, although there is evidence that some specific dietary components or endocrine disruptors may modify breast cancer risk, the effects are generally small and not uniformly confirmed in all studies [17, 18] . One explanation may be that the vast majority of these studies have not taken into consideration a possibility that in order to permanently modify breast cancer risk, the exposures may need to take place at times when the mammary tissue is undergoing extensive modeling or re-modeling; i.e., during fetal development, puberty or pregnancy. Since the focus of this review is to understand the role of TEBs in mediating the effects of diet on breast cancer risk, and since TEBs are present between puberty and young adulthood, findings relating to fetal and pubertal dietary exposures will be briefly reviewed. The roles of dietary exposures during pregnancy on mother's risk are discussed elsewhere [19] .
Maternal Exposures During Pregnancy and Offspring's Breast Cancer Risk
We and others have shown that many maternal exposures that modify hormone levels or hormonal activity during pregnancy, and also during lactation, affect mammary tumorigenesis among female offspring. Over 20 years ago, Bern et al. [20] and subsequently Talamantes et al. [21] and Walker [22] investigated the effect of exposing newborn mice to estradiol (E2) or the synthetic estrogen diethylstilbestrol (DES) on mammary tumorigenesis. Both compounds, when given in utero or between birth and postnatal day 5 -a period that corresponds to the last trimester of fetal development in humans -shortened the latency of spontaneous tumor development in mice [23] . In our studies, maternal exposure to E2 during pregnancy increased carcinogen-induced mammary tumorigenesis among rat offspring [8] .
Attempts to alter the fetal estrogenic environment "naturally" led us to study the effects of maternal dietary exposures on pregnancy hormone levels and offspring's mammary tumorigenesis. We found that maternal exposure during pregnancy to an isocaloric high fat corn oil diet increases female offspring's susceptibility to develop carcinogen-induced mammary tumors as adults [8] . Similar results have subsequently been generated in another rat study [24] , and findings in mice also show that maternal high fat diet during pregnancy increases spontaneous mammary tumorigenesis in the outbred strain offspring [22] and transgene-induced mammary tumorigenesis in c-neu oncogene overexpressing offspring [25] . The increase in mammary tumors in the animals exposed to a high fat diet in utero via a pregnant dam may reflect an increase in the fetal estrogenic environment [8, 26] . Maternal exposure to alcohol also increases pregnancy E2 concentrations and offspring's susceptibility to malignant transformation in rats [9] . We are not aware of any human studies that would have investigated whether maternal diet during pregnancy affects daughters' breast cancer risk. This reflects difficulties obtaining accurate dietary information retrospectively, particularly regarding maternal dietary exposures of women diagnosed several decades later.
Human studies indicate that high birth weight is associated with increased risk of developing premenopausal breast cancer [27] [28] [29] [30] [31] [32] . This could be due to elevated levels of E2 during pregnancy, but may also be related to increased maternal and/or cord blood concentrations of insulin/insulin like growth factor 1 (IGF-1), leptin and/or adiponectin [33] [34] [35] , all of which have been linked to high birth weight. It was recently reported that rat pups' birth weight can be increased by feeding pregnant dams an obesity-inducing diet (OID), and the high birth weight was associated with higher susceptibility to develop 7,12-dimethylbenz[a]anthracene (DMBA) -induced mammary tumors [7] . In this model, leptin, but not E2 levels were significantly elevated in pregnant dams fed the birth weight increasing OID diet [7] . Other studies also indicate that an increase in fetal E2 levels is not the only hormonal modification that affects later breast cancer risk. Maternal dietary exposure to the phytochemical genistein present in soy [36] , whole wheat flour [16] or fish oil [36] all elevate pregnancy E2 levels, but genistein does not alter offspring's breast cancer risk and whole wheat flour and fish oil reduce the risk [16, 36] . Thus, although maternal diet can modify pregnancy E2 concentrations, other diet-induced changes may be more important in determining whether a dietary factor increases, reduces or has no effect on offspring's breast cancer risk.
Maternal Exposures During Pregnancy and Offspring's TEBs
Maternal dietary and hormonal exposures that modify offspring's mammary tumorigenesis also alter mammary gland development, particularly the number of TEBs. Mammary glands of rats exposed to E2 in utero or mice exposed to E2 during the first three days postnatally exhibit increased number of TEBs [8, 37] . Dietary exposures that increase mammary tumorigenesis, such as high birth weight -inducing OID [7] , or maternal exposure to a high fat corn oil diet [8] or alcohol [9] increase TEBs. Some endocrine disruptors, such as Bisphenol A in the plastics and dioxin in food, also increase TEBs following early life exposures [10, 11] . Some maternal dietary exposures that do not alter offspring's mammary tumorigenesis, such as genistein or oat flour, have been found to increase [36] and reduce TEBs [16] , respectively. These findings indicate that although in many instances there is a correlation between the number of TEBs and susceptibility to mammary tumorigenesis among rats exposed to altered hormonal environment in utero, TEBs are not always predictive of breast cancer risk.
Exposures During Postnatal Period and Breast Cancer Risk
A handful of studies have examined whether childhood dietary exposures modify later breast cancer risk in humans. While higher consumption of eggs and vegetable fat during childhood has been reported to be inversely associated with breast cancer risk, or proliferative benign breast disease [38, 39] , additional confirmation data are needed. Additionally, an inverse relationship between adolescent fat intake from milk, cheese and yogurt, and breast cancer risk has been reported [40] . High intake of soy based foods during childhood and adolescence has been linked to reduced breast cancer risk [41, 42] .
In animal studies, prepubertal exposure to genistein, either through diet or as a subcutaneous injection, has been found to reduce carcinogen-induced mammary tumorigenesis in rats [43, 44] . Since genistein exhibits estrogenic activities and prepubertal exposure to E2 also reduces breast cancer risk in rats [45] , these findings have been interpreted to indicate that before puberty onset, administration of estrogens reduces later risk of developing breast cancer. Other dietary compounds, when exposed during lactation that have been reported to reduce susceptibility to malignant transformation in the mammary gland include low fat n-3 polyunsaturated fatty acids (n-3 PUFA) [12] , conjugated linoleic acid (CLA) [13] , flaxseed [46] , and resveratrol [15] . Deficient or excessive amount of Vitamin A [47] or high fat n-3 PUFA [12] in the prepubertal diet increases mammary tumorigenesis, and an exposure to epigallocatechin-3-gallate (EGCG), the major catechin found in green tea does not modify later chemically induced mammary cancer risk [15] . Studies investigating the effects of CLA [13] , vitamin A [47] , resveratrol and EGCG [15] on mammary tumorigenesis exposed rats to these compounds either from weaning until the carcinogen exposure or from birth throughout the rest of the study. In the other studies, dietary exposures took place before weaning between postnatal postnatal weeks 1 and 3.
Exposures During Postnatal Period and TEBs
Of all the prepubertal dietary exposures studied thus far, the ones that reduce later mammary cancer risk also reduce the number of TEBs [12] [13] [14] [15] . Further, life time exposure to EGCG does not modify TEBs, in agreement with its lack of effect on mammary tumorigenesis [15] . However, a high fat n-3 PUFA diet that increases susceptibility to malignant transformation, reduces the number of TEBs and induces extensive lobulo-alveolar development [12] . The results of all these studies demonstrate that although the association between the number of TEBs and mammary cancer risk in general is consistent, the influence of some food components is not consistent with a change in TEBs as a predictor of later cancer risk. 
Early Life Exposures and Cell Proliferation and Apoptosis
Since TEBs differ from mammary ducts and alveolar structures by containing a higher proportion of proliferating cells [48] , one possibility is that those early life exposures that modify the number of TEBs in the direction that is not consistent with later mammary tumor incidence, alter cell proliferation within the TEBs. In support of this idea, an exposure to radiation [49] or power frequency magnetic fields [50] , both of which increase susceptibility to malignant transformation in rats, increase the number of proliferating cells within TEBs. We have noted that in utero exposure to E2 increases, while prepubertal E2 exposure reduces cell proliferation in the TEBs, determined using the proliferating cell nuclear antigen (PCNA) assay [51] . These results are consistent with the increase and decrease in mammary tumorigenesis, respectively, induced by in utero and prepubertal E2 exposures. Some other early life exposures that lead to an increase in mammary tumorigenesis are linked to increased cell proliferation in the mammary glands, and within TEBs in particular [7] . Prepubertal exposure to the high fat n-3 PUFA diet that reduced the number of TEBs and increased mammary tumorigenesis, resulted in an increase in the number of proliferating cells in TEBs [12] . Early life dietary exposures that reduce later susceptibility to mammary cancer, such as a low fat n-3 PUFA diet, have been found to reduce cell proliferation within TEBs [12, 13] .
Once tumorigenesis has been initiated, no changes in cell proliferation are seen in transformed TEBs [52] . Instead, apoptosis is significantly reduced when the normal TEBs are coverted to hyperplasias and further to adenocarcinomas [52] . The lack of involvement of cell proliferation during malignant transformation is supported by an observation that ablation of proliferating cells by intraductal injections of Adv-RSV-tk and gancyclovir and the apparent elimination of >90% of the proliferating cells did not inhibit, but promoted MNU-induced mammary tumors [53] . The authors speculated that the cells still proliferating in the mammary glands of Adv-RSV-tk and gancyclovir exposed rats might have been transformed stem cells which gave rise to transformed progenitor cells with high likelihood of forming tumors.
WHY TEBS MATTER?
One apparent reason why early life dietary and hormonal exposures may modify later breast cancer risk is because they alter the pathways that participate in modeling and re-modeling of the mammary gland during fetal development and puberty. In rats and mice (as well as in humans), the mammary fat pad is initially formed during the fetal period [1, 54] . Several excellent reviews have been written describing the sequence of events from the fetal period to involution that occur in the human and rodent mammary gland [55] [56] [57] , and the readers are encouraged to read these reviews to gain more knowledge relating to mammary gland development. Briefly, in rats and mice whose gestational period lasts for three weeks, the mammary gland development begins after mid-gestation. The primary mammary rudiment penetrates the underlying mesenchyma to form the mammary fat pad that also contains few adipocytes. The rudiment contains a primitive ductal tree and this tree is quiescent until about 3 weeks of postnatal age, when ovarian hormone production starts and large club-shaped TEBs appear. TEBs are located at the tips of growing epithelial ducts and consist of a mass of body cells and a top layer of cap cells. TEBs regress to terminal buds or differentiate to alveolar buds when the epithelial tree reaches the edges of the fat pad.
A recent article by Hinck and Silberstein [58] summarizes what is known about factors which enable TEBs to invade the mammary fat pad. TEBs express several genes whose functions have been linked to motility, including Neogenin [59] , the ephrin receptor ephB4 [60] , the heparin-binding growth factor pleiotrophin (also known as HARP) [61] , epimorphin [62] , basic fibroblast growth factor (bFGF) [63] and hepatocyte growth factor (HGF/SF) [64] . Netrin 1 -neogenin interaction may stabilize TEB architecture by providing physical adhesion between cap and body cells [59] . TEBs express genes of the transforming growth factor (TGF) family that inhibit the forward movement of TEBs [58] . To better understand how early life exposures alter TEBs, the key regulators of mammary gland development are briefly reviewed.
Fetal Period
During the in utero period, signaling molecules important for epithelial-mesenchymal interactions, such as parathyroid hormone related peptide (PTHrP), FGFs, and transcription factors LEF-1, Msx1 and Msx2, participate in the development of the mammary gland [65] . Since mammary epithelial branching during embryonic development occurs in the glands of mice that lack either estrogen receptor (ER) -, ER-, progesterone receptor, or receptors for prolactin and growth hormone, this process is probably hormone independent. However, transplacental estrogens modify both fetal and postnatal mammary gland development. Administration of exogenous estrogens accelerates differentiation of the nipple and causes extensive proliferation of the surrounding mesenchyma during the fetal period [66] . Further, hormones and hormone-affecting compounds when given during in utero or postnatal period modify postpubertal mammary gland development [8, 23, 37, [67] [68] [69] [70] .
Puberty
Puberty in rats and mice begins at about 4 weeks of age, and it is marked by vaginal opening. Estrogens are necessary for pubertal mammary epithelial growth [71] . It has been shown that ovariectomy at puberty causes TEB regression and halts ductal growth [72] . Further, ER-knockout (ERKO) mice do not form TEBs and their mammary ducts do not elongate [73] . However, although estrogens are necessary for pubertal mammary growth, they are not sufficient. Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) are needed. GH acts on the mammary stroma, where it activates the release of IGF-1, and IGF-1 in turn stimulates proliferation of the mammary epithelium [74] . Epidermal growth factor (EGF) may also be important [75] , since EGF receptor knockout (EGFRKO) mice exhibit a defect in ductal elongation prior to puberty onset [23] . EGFR ligands also can rescue mammary gland development in ovariectomized or ERKO mice [76] . TGF-appears to be the primary inhibitor of ductal elongation as well as lateral branching, at least during postnatal period [77, 78] . Although progesterone and prolactin are important for branching of the mammary ducts [23, 79] , they may be needed only during pregnancy and lactation [80] . Lack of progesterone or prolactin signaling has no apparent effect on mammary gland development during adolescence [81] . Since many of these hormones and growth factors either are secreted from the stroma or have stromal sites of action, the stromal-epithelial interactions are essential in regulating the pubertal mammary gland development.
HOW DO CHANGES IN THE HORMONAL ENVIRON-MENT DURING EARLY DEVELOPMENT MODIFY MAM-MARY GLAND DEVELOPMENT?
The concept that susceptibility to various diseases is established in utero is mainly based on studies showing that low birth weight is associated with increased risk of developing various diseases, including cardiovascular diseases, hypertension, Type-2 diabetes, insulin resistance, and obesity [82, 83] . It has been proposed that an unfavorable prenatal environment can lead to low birth weight that in turn triggers epigenetic changes to improve the chances of survival postnatally [84] . During fetal development, epigenetic reprogramming interprets the information in the genetic code by means that do not involve a change in DNA sequence [85] . The most common epigenetic alteration is methylation of cytosine in the 5'position in CpG dinucleotides in a gene's promoter region, resulting in silencing of gene expression. Another common form of epigenetic regulation involves modifications of histones that can result in activation or inactivation of chromatin. The epigenetic modifications can then be inherited in somatic daughter cells, so that cell identity is maintained throughout life. The scheduled epigenetic reprogramming can be modified by factors that influence the epigenome, such as those causing a low birth weight; as a result, the normal postnatal development is altered in a manner that leads to increased disease susceptibility.
Besides low birth weight, there are several other examples of altered fetal environment having caused persistent modification in gene expression and also in susceptibility to disease. In humans and animal models, intake of folic acid during pregnancy prevents neural tube defects by enhancing methylation of CpG motifs. If folic acid levels are low, the pool of progenitor cells in the fetal forebrain is reduced [86] , suggesting that hypomethylation of certain genes interferes with progenitor pool expansion resulting in structural and functional brain defects. Another example are mice carrying the agouti viable-yellow allele (A vy ); a litter of these mice exhibit a range in coat color from completely yellow to mottled to wild-type, dark agouti. The completely yellow phenotype is associated with metabolic defects, including obesity, hyperinsulinemia, and shorterlife span, whereas the darker, wild-type agouti mice are leaner, normoinsulinemic, and have longer-life spans. Maternal exposure to methyl-supplemented diets or genistein during pregnancy results in the birth of greater numbers of the wild-type agouti mice over agouti yellow coated mice due to increased methylation of CpG motifs in a retrotransposon (IAP) upstream of the agouti promoter [87] . Further, maternal exposure during pregnancy to Bisphenol A, a compound in plastic with endocrine activities, increases offspring's prostate cancer risk and induces hypomethylation of phosphodiesterase type 4 variant 4 (PDE4D4), an enzyme responsible for cyclic AMP breakdown [88] .
Persistent epigenetic changes are not limited to exposures that take place during the fetal period; these changes can be induced by exposures that occur during the postnatal period, although it is not known at which point the epigenome looses its ability to acquire lifelong modifications. Vickers et al. [89] have shown that neonatal exposure to leptin normalizes the programmed effects of fetal undernutrition on end-points that included weight gain and plasma levels of glucose and insulin; however, it is not known whether this is a result of leptin affecting epigenetic regulation of gene expression. Another study found that postweaning exposure to a synthetic methyl-donor deficient diet induced loss of imprinting in the insulinlike growth factor 2 (Igf2) locus in the kidney that persisted beyond switching the mice to the natural ingredient diet [90] .
Epigenetic Changes and Mammary Gland Morphology
Epigenetic changes can drive changes in mammary gland morphology. Acini formation within the cultured human mammary epithelial cells is associated with epigenetic changes in the expression of genes regulating chromatin remodeling, suggesting that DNA methylation coordinates mammary epithelial differentiation [91] . These epigenetic changes can also affect stem cells: they have been shown to shift the ratio of differentiated to undifferentiated stem and progenitor cells in the colon crypts of mice with a mutation at the Apc gene [92] . Further, tissue specific stem cells are found to be direct targets of transient methylation disruption [93] .
In Utero Dietary Exposures and Changes in Mammary Gland Gene Expression
The possibility that altered fetal hormonal environment modifies later breast cancer risk by inducing epigenetic changes in the mammary gland needs to be investigated. In rats, in utero exposure through a pregnant dam to an isocaloric high fat corn oil diet that increases pregnancy E2 levels and offspring's mammary tumorigenesis [8] , also induces hypomethylation of ER in an adult mammary gland [94] . This would suggest that epigenetic changes mediate the effects of elevated pregnancy hormone levels on offspring's risk of developing breast cancer. However, it is unlikely that hypomethylation of GpC promoter regions is the only epigenetic mechanism that mediates the effects of altered fetal or prepubertal environment on later breast cancer risk. For example, maternal exposure to DES during pregnancy that increases uterine cancer risk in daughters [95] and female mouse pups [96] , induces persistent expression of the proto-oncogene c-fos and lactoferrin genes, and permanent repression of Hoxa-10 and Hoxa-11 in the female uterine tract [97] . Although the changes in c-fos and lactoferrin expression resulted from hypomethylation of GpC promoters, changes in Hoxas might reflect changes in chromatin structure induced by histone modifications.
To begin to unravel the genes that are targeted by early life dietary exposures, the genes whose expression is altered following either in utero or prepubertal dietary exposures is briefly high-lighted. High birth weight rats, which develop mammary tumors earlier than the control rats, exhibit significantly reduced mammary -expression [7] . Maternal exposure to leptin also reduces mammary ERcontent, indicating that elevated fetal leptin levels may have caused down-regulation of ER-. High birth weight is associated with increased activation of Mitogen-Activated Protein Kinase (MAPK) in an adult mammary gland [7] . MAPK is involved in the signaling of multiple pathways. Increased expression of growth factors, such as transforming growth factor (TGF) or EGF, leads to overactivation of MAPK. Microarray analysis data from our laboratory indicate that high birth weight and fetal leptin exposure are both associated with increased expression of TGF mRNA (Yu et al., unpublished data). High birth weight also is associated with reduced expression of TGF -inducible early response gene (TIEG), a unique regulator of TGF signal transduction pathway. Since TIEG inhibits cell proliferation [98] , its down-regulation in the mammary glands of high birth weight rats might be causally linked to increased cell proliferation. Some dietary factors, including whole wheat flour, when fed to pregnant dams reduce female offspring's mammary tumorigenesis, up-regulate tumor suppressor genes BRCA1 and p53 in the offspring's mammary gland [16] .
To identify genes targeted by altered in utero hormonal environment that increase later susceptability to develop mammary tumors, we compared gene expression patterns in the mammary glands of high birth weight rats and rats exposed to an excess of leptin or E2 during fetal period. Only one gene was identified from the microarray analysis as being up-regulated and another gene as down-regulated in all three groups, and these two genes regulate cell metabolic and inflammatory processes, respectively. Taken together, maternal dietary exposures during pregnancy that modify offspring's later breast cancer risk appear to alter expression of genes that provide protection against breast cancer development by affecting tumor suppressor functions, but also genes that regulate metabolic processes and possibly inflammation.
Pubertal Hormonal/Dietary Exposures and Changes in Mammary Gland Gene Expression
Since many prepubertal dietary exposures are known to reduce later breast cancer risk, expression patterns of genes that are affected by these protective exposures may provide clues on the pathways linked to susceptibility to develop this disease. These genes are probably related to cell proliferation, apoptosis and differentiation, because these end-points are affected by early life exposure to E2, genistein [45] , CLA [13] or resveratrol [15] . We have found that an exposure to E2 or genistein during prepuberty exhibit increased expression of BRCA1 mRNA in the rat mammary gland [45] . Further, prepubertal E2 and/or genistein exposures up-regulate the gene expression and protein levels of caveolin-1 [99] and Pten [100] , suggesting an increase in tumor suppressor functions.
Expression of multiple genes known to be linked to breast cancer risk is different in the mammary glands of rats that were fed either a low or high fat n-3 PUFA diet before puberty onset and that then exhibited reduced and increased mammary tumorigenesis, respectively [12] . Consistent with the known action of n-3 PUFAs in affecting lipid metabolism and activating nuclear receptor PPAR , prepubertal exposure to n-3 PUFA diets reduces COX-2 activity and increases PPAR expression [101] . Further, high fat n-3 PUFA exposed rats exhibit down-regulation of genes that protect cells from oxidative stress due to lipid peroxidation [101] . Rats fed low and high fat n-3 PUFA diets during prepuberty exhibit opposite changes in BRCA1 expression [12] , but both increase caveolin-1 expression [99] . Thus, a change in an expression of a single gene is not sufficient to predict whether a prepubertal dietary exposure is protective or not. The findings nevertheless suggest that dietary exposures before puberty onset that alter later breast cancer risk modify genes that have tumor suppressor or antioxidant functions.
MAMMARY STEM CELLS
TEBs as well as other mammary structures originate from somatic stem cells that when implanted to an empty mammary fat pad can build an entire epithelial tree [102, 103] . In an adult mammary gland, stem cells are rare but have a high proliferative potential and self-renew upon cell division. Stem cell division is either asymmetric, resulting in one stem cell and one daughter cell, or symmetric resulting in two stem cells. The daughter cells, also called progenitor cells, undergo a rapid cell division, and give rise to intermediate progenitor cells that are committed to differentiate into either myoepithelial or luminal cells [104] . The differentiation takes place for example when the TEBs move forward in the fat pad: the inner body cells give rise to the inner luminal epithelial cell layer and the cap cells give rise to the outer myoepithelial cell layer [104] . It has also been shown that myoepithelial cells can originate from luminal cells, but not vice versa [105, 106] , suggesting that myoepithelial cells are the most differentiated cells in the mammary gland. Since the cap cells not only give rise to myoepithelial cells, but to body cells (luminal cell progenitors) as well [107] , it has been speculated that cap cells are stem cells [104] . Others believe that cap cells are merely the cells that regulate motility of TEBs [108] .
Stem cells have a long life, probably partly because they are resistant to apoptosis, and thus can accumulate DNA damage and mutations, making them ideal candidates for the initiation of cancer [104] . Recently, stem cells from human breast tumors were identified, viably isolated and serially transplanted into immunocompromised athymic mice [109] . These cells produced tumors identical to the parent tumor, and when similar cells isolated from the transplanted tumor were transplanted into a second and third group of mice, they retained their capacity to produce tumors containing cells histologically and biochemically (phenotypically) identical to those of the parent tumor. Since retention of tissue and cell phenotype through serial transplantation is the biological assay for stem cell characteristics, these cells were named "breast cancer stem cells" [110] . Other evidence in support of the idea that mammary tumors originate in stem cells is that human and rodent mammary hyperplasias are clonal in nature [111] , demonstrating that they were derived from a single parent cell.
Luminal and Myoepithelial Cells
The existence of the two differentiated cell types in the mammary epithelial tree serves to fulfill the biological purpose of mammary glands: to provide milk for the offspring. Myoepithelial cells form an outer layer and luminal cells the inner layer in ducts and alveolar structures. They have different roles: luminal cells are secretory and during lactation alveolar luminal cell produce milk that is collected in the ducts, whereas myoepithelial cells are contractile and they generate the movement to expel milk through the nipple.
The two cell types might have opposing roles in mammary tumorigenesis. Since breast tumors are composed of either luminallike cells or mixed luminal-and basal/myoepithelial-like cells [112, 113] , the luminal cell lineage is thought to be where breast cancers are initiated. Myoepithelial cells, in contrast, might prevent malignant transformation [114] . They are part of the mammary stem cell niche [115] where they regulate stem cell self-renewal and differentiation [116] [117] [118] . Myoepithelial cells express many tumor suppressor genes that affect phenotype through changes in protein expression, perhaps resulting from epigenetic modifications, rather than through genetic mutations, including caveolin-1, BRCA2, and p53 [119] [120] [121] . These cells also express growth factor receptors, matrix metalloproteinases (MMPs), and various protease inhibitors. Cancer myoepithelial cells may be different from the myoepithelial cells in a normal mammary gland. Rather than suppressing tumor growth, they may act to induce growth, migration, and invasion of breast cancer cells, undermining the integrity of basement membrane [114] . It is possible that those early life exposures which increase later breast cancer risk affect signaling in the myoepithelial cells in a manner that prevents their tumor suppressor functions.
Although several markers for luminal and myoepithelial cells have been proposed, the search for specific markers for the two mammary cell lineages is ongoing [122] . Cytokeratins (CKs) are most commonly used to identify luminal and myoepithelial cells. Basal potent progenitor cells that can give rise to either luminal or myoepithelial cell lineages express CK 5/6, and this cytokeratin also is expressed in committed luminal and myoepithelial cell progenitors. In addition, the committed luminal progenitors express CK 8/18 and myoepithelial progenitors express CK 14 and -smooth-muscle actin ( -SMA). Fully differentiated luminal cells express CK 8/18 and casein (only alveolar cells), and myoepithelial cells CK 14 and -SMA [123, 124] ; neither of these cell types express CK 5/6. Other potential myoepithelial cell markers include vimentin and p63. It was recently suggested that luminal cells express high levels of CD24, whilst myoepithelial cells express moderate levels of this antigen [123, 124] . CD24 is a member of cluster designation antigens that have been proven to be very useful in lineage study of hematopoietic cell types.
To understand how early life dietary exposures modify later susceptibility to malignant transformation, studying whether they alter stem cell fate by affecting luminal and myoepithelial cell differentiation is needed. For example, exposures that increase breast cancer risk may prevent myoepithelial cell differentiation, and this could be manifested as an increased population of myoepithelial progenitor cells and reduced population of cells that express markers of fully differentiated myoepithelial cells. Further, characterization of possible differences in signaling pathways within uncommitted, committed and differented myoepithelial cells is needed.
Stem Cell Niche
Niche is a local environment that surrounds stem cells and is important for the regulation of self-renewing ability of a stem cell [125, 126] . Niche has both anatomical and functional dimensions that allow stem cells to self-renew and proliferate; i.e., they are critical in maintaining a pool of stem cells. Loss of niche can lead to loss of stem cells, and functional alterations in niche may be responsible for cancer initiation [118] . Niches normally contain at least two stem cells and several progenitor cells [127] . It has been shown that if a niche loses its stem cells, it can be filled by the progeny of another stem cell or it transforms a nearby differentiated cell to exhibit stem cell like properties [127] . A target of intense research has been how niche signals regulate gene expression within stem cells. Recent evidence indicates that chromatin remodeling factors are involved [126] , including ATP-dependent factors [125] .
Although the stem cell niche has been identified for several organs, such as skin, intestine, nervous system, and hematopoetic system [117] , the mammary stem cell niche has been characterized only ultrastucturally [128] . Myoepithelial cells likely play an important part of the mammary stem cell niche [115] . Therefore, characteriation of mammary stem cell niche may be a critical step towards understanding mammary stem cell self-renewal.
Regulators of Stem Cell Fate
Stem cell fate; i.e. differentiation along specific lineage pathways, is regulated by multiple factors that affect stem cell proliferation within the niche or make the stem cells leave the niche to differentiate. Further advances in understanding mammary gland biology and differences in susceptibility to malignant transformation require that 'master regulatory complexes' of cell proliferation and differentiation are identified. Epigenetically regulated chromatin remodeling factors in niches probably influence gene expression in stem cells to activate genes linked to proliferation and to repress genes that induce differentiation [125] .
In the mammary gland, Wnt/ -catenin, caveolin-1, Notch and Hedgehog signaling pathways have been implicated in mammary stem/progenitor cell fate [107, 129] . For example, Notch family may promote stem cell proliferation along the myoepithelial lineage [130] and inhibit cell differentiation [131] . Increased expression of Wnt or reduced expression of caveolin-1, in turn, increases the number of progenitor cells and prevents their differentiation [129, 132] . Wnt may control Notch expression [133] . Further, TGF and TGF signaling pathways have been implicated in the regulation of stem cell self-renewal and fate [134, 135] , and they are up-and downregulated, respectively, in the mammary glands of rats which had a high birth weight.
A global model to explain how cell fates are determined by the selective depression of a subset of differentiation genes has been proposed by Spradling and Buszczak [126] . According to their model, transcription factors that include OCT4, NANOG and SOX2 establish active and inactive genes during embryonic development. Postnatally, a group of genes called Polycomb (PcG) would maintain the repression of genes regulating differentiation, until lineage specific genes are activated through intercellular signals that result de-repression of PcG genes. Relatively little is known about the genes that regulate PcG, but a recent study found that MAPKAP kinase 3, a convergence point downstream of activated ERK and p38 signaling pathways phosphorylates PcG protein Bmi1 [136] . The observations that high birth weight that increases mammary cell proliferation and susceptibility to mammary tumorigenesis, is associated with increased activation of Mitogen-Activated Protein Kinase (MAPK) in an adult mammary gland [7] , provides indirect evidence to support the involvement of changes in stem cell fate in mediating the effects of fetal environment on later mammary cancer risk. Further, other studies indicate that dietary factors can influence stem cell proliferation and differentiation; i.e., insulin signals from the brain impact the rate of stem cell division in the Drosophila ovary [137] suggesting that maternal diet during pregnancy may be able to affect mammary stem cell fate.
In summary, it is not known whether the fetal hormonal environment might modify self-renewal of mammary stem cells and stem cell fate. Trichopoulos and his collaborators have hypothesized that elevated in utero hormone and/or growth factor levels increase later mammary cancer risk by increasing the total number of replicating immature stem cells and eventually the number of cells at risk for malignant transformation [138, 139] . We suggest that changes in the fetal hormonal environment induced by maternal diet during pregnancy lead to epigenetic changes in the stem cell niche that then affect stem cell fate. These changes are likely to be expressed in the postpubertal TEBs. Evidence already exists that dietary factors including folic acid, genistein in soy foods and epigallocatechin gallate, a polyphenol in green tea [140, 142] can alter epigenetic events and may therefore have particular relevance in regulating stem cell self-renewal and fate.
Identification of Mammary Stem Cells
A major obstacle in studying the role of mammary stem cells is the difficulty in identifying them. Tissue specific stem cells are hard to identify; it is not clear whether even in the hematopoietic systemwhich is the most studied and best characterized regarding stem cells -the right identification markers are known. The marker that perhaps best characterizes stem cells is based on lineage-labeling to identify hierarchy among stem cells, progenitors and differentiated cells. Unfortunately the resulting data are controversial and confusing. One approach to identify mammary stem cells includes separation of a side-population (SP) in the flow cytometry as cells that quickly efflux Hoechst dye [107, 143] . These SP cells are enriched in bromodeoxyuridine (BrdU) retaining cells and they do not express differentiation markers for myoepithelial and luminal cells, but can reconstitute epithelial tree that contains both mammary lineages. Further, the SP expresses high levels of ER- [144] . However, only a very few of SP cells may be actual stem cells [145] .
A second approach to identify mammary stem cells is to purify cell fractions in the flow cytometry from the total mammary cell population by using antibodies that bind to cell surface integrins 6 (CD49f) or 1 (CD29), and CD24 [103, 145] . These double positive (DP) integrin expressing cells are enriched myoepithelial cells, but nevertheless single cells from this fraction can give rise to a whole mammary gland. Cells that do not express CD49f/CD29 and CD24 do not seem to exhibit stem cell activity; i.e., cells that are double staining for the two antibodies contain practically all stem cell activity. Nevertheless, it has been estimated that only 6% of DP cells might be the stem cells [146] . Interestingly, these cells do not express ER- [147] . It is possible that both techniques to identify mammary stem cells are accurate, but the SP represents stem cells in luminal lineage and the DP in myoepithelial lineage.
Yet another way to identify mammary stem cells is to label mammary gland cells with BrdU: since slow-dividing stem cells will retain the label the longest, they can be identified by chasing the cells after a long follow-up. It has been shown that the label retaining cells (LRCs) are an undifferentiated cell population and they are enriched in the side population [148] . Approximately half of LRCs express ER-, suggesting that mammary stem cells can be either positive or negative for this receptor [149] . The LRC may not be a more useful approach to identify mammary stem cells than the other methods currently in use, since many stem cells proliferate regularly and some do not [150] .
Mammary stem cells and other mammary epithelial cells also have been characterized ultrastructurally in an adult mouse and rat mammary gland [128, 151, 152] . Stem and early progenitor cells are morphologically small, lightly staining cells with an undifferentiated cytoplasm, and are basally located, without contacting the ductal lumen. When they undergo asymmetric division, undifferentiated large light cells are formed. These cells are likely to be progenitor cells that upon further division form differentiated large light cells and large darker cells. The latter are equivalent to luminal cells. The genesis of myoepithelial cells is less well-described, and it is possible that small light cells are stem/progenitor cells specifically for luminal cells. Although the ultrastructural approach to identify mammary stem and progenitor cells is promising, its weaknesses are the time commitment required to identify the cells and the fact that there is no direct evidence that the small light cells indeed are the mammary stem cells.
To summarize, at present time there is no gold-standard to guide the identification of mammary stem cells. Specific markers for luminal and myoepithelial cells are also been sought to gain information on the stem cell fate. The most fruitful approach to identify stem cells might be to identify both the side population and the double positive (CD49f/CD29 and CD24) stem cell enriched myoepithelial cell population. However, since stem cell niche can convert a differentiated cell to exhibit stem cell like properties if this cell re-populates an empty stem cell niche [127] , characterization of mammary stem cell niche may be the most important task to understand breast cancer risk.
CONCLUSIONS
Accumulating evidence indicates that early life dietary exposures that modify fetal or prepubertal hormonal environment affect later breast cancer risk. The increase in risk seen in offspring of rodents consuming a high fat diet [8] , obesity-inducing diet [7] or alcohol during pregnancy [9] may occur as a consequence of either (i) altered gene expression within stem/progenitor cells regulating stem cell fate, (ii) altered ability of stem cell niche to control stem cell self-renewal, or (iii) increased number of TEBs or stem cells within TEBs (Fig.  (2) ). If uncommitted stem/progenitor cells in the luminal cell lineage are the ones where mammary cancer initiation takes place, then their number might be increased. The gland exhibiting increased susceptibility to malignant transformation may also contain increased number of uncommitted myoepithelial cells that fail to differentiate to myopeithelial cells that normally protect the stem cells. Myoepithelial cells may also exhibit reduced expression of tumor suppressor genes. There is evidence to support the idea that TEBs are altered, since many early life exposures that increase later breast cancer risk, increase the number of TEBs and/or increase cell proliferation and reduce apoptosis within TEBs. An important question also is what determines the number of TEBs, and a probable answer is gene expression regulating stem cell fate and stem cell self-renewal within the niche. More attention to model systems exhibiting changes in pathways regulating stem cell self-renewal and fate should help resolve the conundrum of why some dietary manipulations in utero or during prepuberty influence breast cancer risk, and why the same exposures in utero may have opposite effects than prepubertal exposures on the breast.
Once the mechanisms mediating the effects of early life dietary exposures on the risk of developing breast cancer are revealed, strategies for cancer prevention can become a reality. If epigenetic changes are involved, they could potentially be reversed by consumption of dietary constituents during adult life that influence the molecular targets modified by early life exposures [140] .
